Utama › Limfoma Sel B Besar Difus › Virginia › Richmond
Kajian klinikal Limfoma Sel B Besar Difus di Richmond, VA
10 kajian untuk Limfoma Sel B Besar Difus sedang mencari peserta di lokasi dalam dan sekitar Richmond (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
Mengambil pesertaFasa 2
- VCU Massey Comprehensive Cancer Center, Richmond
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Mengambil pesertaFasa 1/2
- Virginia Commonwealth University Massey Cancer Center, Richmond
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
Mengambil pesertaFasa 3
- Virginia Cancer Institute ( Site 0148), Richmond
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Mengambil pesertaFasa 2
- VCU Health Adult Outpatient Pavillion ( Site 0138), Richmond
A Study of ARC-02 in B-cell NHL
Mengambil pesertaFasa 1
- Massey Cancer Center, Richmond
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Mengambil pesertaFasa 1/2
- Virginia Commonwealth University-Massey Cancer Center, Richmond
Epcoritamab Plus Ibrutinib for the Treatment of Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma
Mengambil pesertaFasa 1/2
- VCU Massey Comprehensive Cancer Center, Richmond
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Mengambil pesertaFasa 2
- VCU Massey Comprehensive Cancer Center, Richmond
Zanubrutinib in Patients With DLBCL and MYD88 or NOTCH1 Mutation or CD5+
Mengambil pesertaFasa 2
- Virginia Commonwealth University, Richmond
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
Mengambil pesertaFasa 2
- VCU Massey Cancer Center at Stony Point, Richmond
- VCU Massey Comprehensive Cancer Center, Richmond
Kajian Limfoma Sel B Besar Difus di bandar lain
- New York City, NY21 kajian
- Baldwin Park, CA19 kajian
- Chicago, IL18 kajian
- Houston, TX17 kajian
- Los Angeles, CA17 kajian
- Boston, MA16 kajian
- Milwaukee, WI16 kajian
- Nashville, TN15 kajian
- Portland, OR15 kajian
- Philadelphia, PA15 kajian
- Durham, NC14 kajian
- Dallas, TX13 kajian
Kajian lain di Richmond
- Kanser Payudara26 kajian
- Kanser Paru-paru Bukan Sel Kecil25 kajian
- Kanser Prostat19 kajian
- Kegagalan Jantung16 kajian
- Kanser Paru-paru14 kajian
- Kanser Kolorektal13 kajian
- Penyakit Kardiovaskular13 kajian
- Penyakit Hati Steatotik12 kajian
- Leukemia Mieloid Akut12 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher12 kajian
- Kanser Metastatik12 kajian
- Melanoma11 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.